GLP-1RAs improve glycemic control, reduce body weight, and protect against kidney disease progression.7 Our genetic findings support the hypothesis that higher GLP1R expression may have nephroprotective effects beyond outcomes related to weight loss and glycemic control. The gene discussed is GLP1R; the disease is kidney disorder.